Abstract: An overshoot-free fast start-up bandgap reference circuit (100), a chip, and an electronic device. The bandgap reference circuit (100) comprises a bias current generating unit (101) and a reference core unit (102), wherein an output end of the bias current generating unit (101) is connected to an input end of the reference core unit (102), the bias current generating unit (101) generates a bias current (IBIAS) unrelated to the voltage of a power supply and having a zero temperature coefficient, the bias current (IBIAS) is an input signal of the reference core unit (102), and the reference core unit (102) generates a pre-charging current on the basis of the input bias current (IBIAS) and implements overshoot-free fast start-up by means of employing pre-charging.

Abstract: A power measurement circuit, a chip and a communication terminal. The power measurement circuit comprises a power measurement unit (100), a reference current generation unit (200), a voltage-current conversion unit (300) and an operation output unit (400), wherein an output end of the power measurement unit (100) is connected to an input end of the voltage-current conversion unit (300), and an output end of the voltage-current conversion unit (300) and an output end of the reference current generation unit (200) are respectively connected to an input end of the operation output unit (400). By means of the circuit, during the process of a power measurement unit (100) converting, into a direct-current voltage, a received radio frequency signal to be measured, sensitivity adjustment is performed, such that the measurement sensitivity can be effectively adjusted.

Abstract: An adaptive overshoot-voltage suppression circuit (100), a reference circuit, a chip and a communication terminal. The adaptive overshoot-voltage suppression circuit (100) comprises an overshoot-voltage suppression unit (1001) and a voltage-current conversion unit (1002), wherein an input end of the overshoot-voltage suppression unit (1001) is connected to a preset sampling point on a reference circuit to be tested, an output end of the overshoot-voltage suppression unit (1001) is connected to an input end of the voltage-current conversion unit (1002), and an output end of the voltage-current conversion unit (1002) is connected to a preset adjustment point on said reference circuit.

Abstract: A pyram-shaped deep-sea pressure-resistance shell and a design method therefor. The shell comprises a conical shell, an annular combined shell, a cylindrical shell, a flange bolt, and a perforated thick plate; a bottom end of the conical shell is connected with a top end of the annular combined shell, the conical shell being in communication with an interior part of the annular combined shell; the perforated thick plate blocks the bottom end of the annular combined shell, the perforated thick plate and the annular combined shell being connected by means of multiple flange bolts; the cylindrical shell is disposed inside the annular combined shell, a lower end of the cylindrical shell being inserted in a gap between the annular combined shell and the perforated thick plate.

Abstract: A displaying base plate and a manufacturing method thereof, and a displaying device. The displaying base plate includes a substrate, and a first electrode layer disposed on one side of the substrate, wherein the first electrode layer includes a first electrode pattern; a first planarization layer disposed on one side of the first electrode layer that is away from the substrate, wherein the first planarization layer is provided with a through hole, and the through hole penetrates the first planarization layer, to expose the first electrode pattern; and a second electrode layer, a second planarization layer and a third electrode layer that are disposed in stack on one side of the first planarization layer that is away from the substrate, wherein the second electrode layer is disposed closer to the substrate, the second electrode layer is connected to the first electrode pattern and the third electrode layer.

Abstract: An action recognition method includes: obtaining original feature submaps of each of temporal frames on a plurality of convolutional channels by using a multi-channel convolutional layer; calculating, by using each of the temporal frames as a target temporal frame, motion information weights of the target temporal frame on the convolutional channels according to original feature submaps of the target temporal frame and original feature submaps of a next temporal frame, and obtaining motion information feature maps of the target temporal frame on the convolutional channels according to the motion information weights; performing temporal convolution on the motion information feature maps of the target temporal frame to obtain temporal motion feature maps of the target temporal frame; and recognizing an action type of a moving object in image data of the target temporal frame according to the temporal motion feature maps of the target temporal frame on the convolutional channels.

Abstract: Disclosed is a reactor operation optimization method based on an improved multi-population genetic algorithm. The reactor operation optimization method includes the following steps: defining an operating condition, and designing an operating scheme according to the operating condition; obtaining operating data of the reactor system of the operating scheme through numerical simulation research, and obtaining operation indexes by calculating the operating data; optimizing the operation indexes based on an improved multi-population genetic algorithm to obtain an optimization result; obtaining an optimal operating parameter setting under the operating condition according to the optimization result. The application solves the problem that the design scheme of reactor operation control hardly meets actual operation requirements, and therefore improves operation characteristics of the reactor system.

Abstract: A DNA movable type storage system and method based on movable type printing including: (1) construct a physical DNA movable type library of data payloads and a physical DNA movable type library of indexes based on “DNA movable type codebook”, which consist of a variety of DNA oligonucleotides corresponding to all “DNA payload movable type elements” and “DNA index movable type elements” in the two libraries, respectively; (2) transcode from the storage binary data into corresponding “DNA movable type units”, each of which contains corresponding DNA payload movable type elements and related DNA index movable type elements; (3) link the abovementioned DNA payload and index movable type elements to form a physical “DNA movable type unit”, and put all generated DNA movable type units together for DNA storage, which cover all data information of the target file.

Abstract: A park assist system includes a controller that executes park assist control with which a vehicle is automatically parked in a parking spot. The controller is configured to set a point at a position higher than the vehicle and across the vehicle from the parking spot as a viewpoint used to generate the parking spot image, set an angle according to a parking spot distance that is an actual distance between the vehicle and a parking spot shown by the parking spot image as a depression angle used to generate the parking spot image, generate a parking spot image by using the set viewpoint and depression angle, cause a display device to display the parking spot image, and park the vehicle with the park assist control in a parking spot set by the driver as a target parking spot by way of viewing the parking spot image.

Abstract: The present invention provides a pharmaceutical composition comprising (R, E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy) phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidinyl-2-yl)-acrylamide or a pharmacologically acceptable salt thereof, which is obtained by mixing the quinoline derivative or a pharmacologically acceptable salt thereof, a wetting agent, a disintegrant, and at least one pharmaceutical excipient; granulating; dynamic drying; and optionally compressing into tablets or filling into capsules after mixing with a lubricant.

Abstract: The parking assist apparatus comprises an ECU. When the ECU recognizes a perpendicular-parallel parking possible space to which a vehicle can not only be perpendicularly parked from a parking start position but also be parallelly parked from the parking start position, the ECU is configured to display any one of a first perpendicular-parallel parking space selection button and a second perpendicular-parallel parking space selection button in such a manner that one of the buttons is superimposed on the perpendicular-parallel parking possible space.

Abstract: An ERVC for floating nuclear power plants includes a containment, a reactor vessel, a liquid gallium collection tank, a heat pipe, a cooling cabin and a gallium storage tank. The containment is arranged in a sea environment, and the containment is provided with a containing cavity; the reactor vessel and the liquid gallium collection tank are arranged up and down and located in the containing cavity. An end of the heat pipe is inserted into the liquid gallium collection tank, and another end thereof is arranged outside the liquid gallium collection tank; the gallium storage tank is located in the containing cavity; the gallium storage tank is connected to the liquid gallium collection tank through a liquid gallium release valve; and the cooling cabin is located under the containment and under a sea level of the sea environment.

Abstract: A park assist system includes a controller that executes park assist control with which a vehicle is automatically parked in a parking spot. The controller is configured to set a point at a position higher than the vehicle and across the vehicle from the parking spot as a viewpoint used to generate the parking spot image, set an angle according to a parking spot distance that is an actual distance between the vehicle and a parking spot shown by the parking spot image as a depression angle used to generate the parking spot image, generate a parking spot image by using the set viewpoint and depression angle, cause a display device to display the parking spot image, and park the vehicle with the park assist control in a parking spot set by the driver as a target parking spot by way of viewing the parking spot image.

Abstract: The present invention provides a pharmaceutical composition containing a quinoline derivative or a salt thereof. Specifically, the invention provides a pharmaceutical composition containing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide or a pharmaceutically acceptable salt thereof, a cross-linked polyvinylpyrrolidone, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition has a property of rapid dissolution.

Abstract: The present invention provides a pharmaceutical composition comprising quinoline derivative. Specifically, the present invention provides a process for preparing a pharmaceutical composition comprising (R, E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy) phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidinyl-2-yl)-acrylamide or a pharmacologically acceptable salt thereof. The process for preparing is suitable for large-scale industrial production, and the obtained sample has the characteristics such as rapid and uniform dissolution.

Abstract: The parking assist apparatus comprises an ECU. When the ECU recognizes a perpendicular-parallel parking possible space to which a vehicle can not only be perpendicularly parked from a parking start position but also be parallelly parked from the parking start position, the ECU is configured to display any one of a first perpendicular-parallel parking space selection button and a second perpendicular-parallel parking space selection button in such a manner that one of the buttons is superimposed on the perpendicular-parallel parking possible space.

Abstract: The present invention provides a pharmaceutical composition containing a pyrrolo-fused six-membered heterocyclic compound or a pharmaceutically acceptable salt of the compound. Specifically, the invention provides a pharmaceutical composition containing 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidene-methyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one or a pharmaceutically acceptable salt thereof, and at least one water soluble filler. The pharmaceutical composition of the invention features a rapid dissolution and good stability.

Abstract: The present invention provides a method for preparing a pharmaceutical composition containing a pyrrolo-fused six-membered heterocyclic compound or a pharmaceutically acceptable salt thereof. Specifically, the invention provides a preparation method of a pharmaceutical composition, the method containing: mixing 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidene-methyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one or a pharmaceutically acceptable salt thereof with at least one filler, and then granulating the mixture. The pharmaceutical composition of the invention features a rapid dissolution and good stability.

Abstract: The present invention provides a method for preparing a pharmaceutical composition containing a quinoline derivative or a salt thereof. Specifically, the invention provides a method for preparing a pharmaceutical composition containing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide or a pharmaceutically acceptable salt thereof. The method uses a wetting agent containing at least one organic solvent for a wet granulation in a preparation process of the pharmaceutical composition. The pharmaceutical composition prepared using the method has a uniform distribution of grain sizes during the preparation process and a property of rapid and uniform dissolution.

Abstract: The present invention provides a pharmaceutical composition containing a quinoline derivative or a salt thereof. Specifically, the invention provides a pharmaceutical composition containing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide or a pharmaceutically acceptable salt thereof, a cross-linked polyvinylpyrrolidone, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition has a property of rapid dissolution.